SAFETY DATA SHEET July 2011 FDS 11.07 1. Name of substance / preparaton and company Product information Item name : HEXAHYDRATED FERRIC CHLORIDE Ref : AR37 AR371 Identification of the substance or the preparation Product name : HEXAHYDRATED FERRIC CHLORIDE Chemical name : Iron trichloride hexahydrated Synonym(s) : Iron chloride III hexahydrated, Iron perchloride hexahydrated Commercial Name : FeCl3 60% Formula : FeC13.6H20 Molecular Weight : 270,31 EC Number (EINECS) 231-729-4 Company : CIF 11 rue Charles Michels 92220 BAGNEUX Tl : 01.45.47.48.00 Fax : 01.45.47.16.14 E-mail : cif cif.fr Web : www.cif.fr 2. Hazards identification Toxicity effects principally related to its corrosive properties. In case of decomposition, releases dangerous products. 3. Composition/ information on ingredients Ferric chloride CAS Number 10025-77-1 EC Number (EINECS) 231-729-4 Symbols C Phrases R 34, 22, 52/53 Concentration 60,00 % 4. First-aid measures General recommendations Strict hygiene during and at the end of working shifts. Personal protective equipment required for rescuers (see section 8). In case of product splashing into the eyes and face, treat eyes first. Submerge soiled clothing in a basin of water. Effects Main effects Irritating to skin corrosive to mucous membrane and eyes. The seriousness of the lesions and the prognosis of intoxication depend directly on the concentration and duration of exposure. Risk of liver effects. Fatalities have been observed after a single dose of 30 grams and more taken by an adult weighing 70 kg. Chronic exposure to the product can induce iron accumulation in tissues characterized by redbrown deposits, Inhalation Severe irritation of the nose and the throat, Cough and difficulty in breathing. In case of repeated or prolonged exposure: risk of sore throat, nose bleeds, chronic bronchitis. In case of repeated or prolonged exposure: risk of brown colouration of teeth, Eyes contact Severe eye irritation, watering, redness and swelling of the eyelids. Burns. Risk of serious or permanent eye lesions. 1/6 4. First-aid measures Skin contact Irritation. When in contact with dame skin, risk of burns. In case of repeated contact: risk of allergic dermatitis. On contact with broken skin, risk of persistent pigmentation Ingestion Dow probability of risk (stinging odour). Severe irritation and risk of burns to the mouth, throat, esophagus and stomach. Nausea, vomiting (bloody), abdominal crames and diarrhea (bloody). Risk of shock. Risk liver and kidney alterations. Risk of chemical pneumonitis and pulmonary (o)edema resulting from aspiration during vomiting. By ingestion of large quantities: risk of convulsions, coma. First aid Inhalation Remove the subject from the contaminated area as soon as possible transport him/her lying down, with the head higher than the body, to a quiet, uncontaminated and well-ventilated location. Oxygen or pulmonary resuscitation if necessary. Keep warm (blanket). Consult with a physician in all cases. Eyes contact Consult with an ophthalmologist immediately in all cases. Flush eyes as soon as possible with running water for 15 minutes, while keeping the eyelids wide open. In the case of difficulty of opening the lids, administer an analgesic eye wash (oxybuprocaine) Skin contact Remove contaminated shoes, socks and clothing under the shower if necessary wash the affected Skin with soap and water. Clean clothing. Consult with a physician in case of persistent pain or redness. Ingestion General recommendations Consult with a physician immediately in all cases. Take to hospital. If the subject is completely conscious: Rinse mouth with fresh water. Do not induce vomiting. if the subject presents nervous, respiratory or cardiovascular disorders: administer oxygen. If the subject is unconscious: Classical resuscitation measures. Medical treatment Inhalation Pulmonary resuscitation (oxygen therapy). Prevention or treatment of pulmonary (o)edema and bacterial secondary infection. Eyes contact On the advice of the ophthalmologist. Skin contact Usual treatment for burns. Ingestion Gastric lavage with a saline solution In case of intense pain: inject an l.M. morphomimetic analgesic drug (piritramide) before taking to hospital. Prevention or treatment for shock. I.V. perfusion of desferrioxamine (40 mg/kg every 3 hrs) associated with hemodialysis in the case of renal failure. Surveillance of hepatic and renal functions. Surveillance of the glycaemia and coagulation tests. Treatment of gastrointestinal tract burns and resulting effects. 2/6